Galapagos NV (NASDAQ:GLPG) Q2 2023 Results Conference Call August 4, 2023 8:00 AM ET

Company Participants

Sofie Van Gijsel - Head, IR

Paul Stoffels - CEO, Chairman, Interim Head, R&D

Thad Huston - CFO and COO

Michele Manto - Chief Commercial Officer

Daniele D'Ambrosio - Head of Immunology

Conference Call Participants

Emily Field - Barclays

Jason Gerberry - Bank of America

Mike Ulz - Morgan Stanley

Brian Balchin - Jefferies

Xian Deng - UBS

Phil Nadeau - TD Cowen

Dane Leone - Raymond James

Sebastiaan van der Schoot - Kempen

Jacob Mekhael - KBC Securities

Operator

Good day and thank you for standing by. Welcome to the Galapagos H1 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Again please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Sofie Van Gijsel. Please go ahead.

Sofie Van Gijsel

Thank you, operator, and welcome all to the audio webcast of Galapagos' H1 2023 Results. I'm Sofie Van Gijsel, Investor Relations representing the reporting team at Galapagos. This recorded webcast is accessible via the Galapagos website homepage and will be available for download and replay later on today.

I would like to remind everyone that we will be making forward-looking statements during today's webcast. These forward-looking statements include remarks concerning future developments of the pipeline and our company and possible changes in the industry and competitive environment. Because these forward-looking statements involve risks and uncertainties, Galapagos' actual results may differ materially from the results expressed or implied in these statements.

Today's speakers will be Paul Stoffels, CEO; and Thad Huston, CFO and COO. Paul will reflect on the operational highlights and provide an update on our pipeline. Thad will go over the commercial and financial results. You will see a presentation on screen. We estimate that the prepared remarks will take about 25 minutes. Then we'll open it up to Q&A with Paul and Thad joined by Michele Manto, Chief Commercial Officer; and Daniele D'Ambrosio, Head of Immunology.

And with that, I'll now turn it over to Paul.

Paul Stoffels

Thank you, Sofie, and thank you all for joining today's webcast. I'm very pleased to introduce to you Thad Huston. Thad joined Galapagos as our new CFO, COO as of July 1. Over the years, Thad gained experience through several positions in finance, commercial, BD and operations. He joined us from Kite Pharma, where he was Senior VP Finance and Corporate Operations and before he was CFO of LivaNova, a listed medtech company.